Delirium, Dementia, Amnestic, Cognitive Disorders  >>  gantenerumab (RG1450)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gantenerumab (RG1450) / Roche, Novartis
NCT00531804: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

Completed
1
60
Europe, RoW
gantenerumab
Hoffmann-La Roche
Alzheimer's Disease
09/10
09/10
NCT01656525: A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients

Completed
1
28
Japan
Gantenerumab, Placebo
Chugai Pharmaceutical
Alzheimer's Disease
03/14
06/14

Download Options